Filing Details

Accession Number:
0001415889-24-025804
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-10-30 20:59:38
Reporting Period:
2024-10-28
Accepted Time:
2024-10-30 20:59:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1746466 Equillium Inc. EQ Pharmaceutical Preparations (2834) 821554746
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1797818 Christine Zedelmayer 2223 Avenida De La Playa, Suite 105
La Jolla CA 92037
Sr. Vice President And Coo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-10-28 15,000 $1.25 135,246 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 19, 2024.
  2. Includes 15,000 shares acquired by the reporting person on June 10, 2024 under the Issuer's 2018 Employee Stock Purchase Plan.